Choice90Rx, unveiled at the National Council for Prescription Drug Programs’ (NCPDP), offers participants the option of going to their pharmacist for face-to-face consultations at the same time providing aggressive pricing equal to or better than that of mail order distribution centers for 90-day prescriptions. This combination of benefits, the company says, lowers plan sponsor drug costs while enhancing consumer satisfaction and quality of care, according to a news release.
Additionally, MedImpact says the program levels the playing field for the local pharmacist. As evidence, MedImpact points to a Walgreens in Michigan that participated in Choice90Rx for an employer, and as a result has seen a 61% increase in market share for employees of that company. In addition, Walgreens average day’s supply of prescriptions filled for that employer increased from 22-day to 42-day supply.
For more Choice90Rx information, please contact Lisa Fletcher, MedImpact’s Choice90Rx Product Manager, at 858-790-7062.
« EEOC Defines 'Applicant' for Internet Recordkeeping